BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2758842)

  • 1. 3H-ZK 98,734, a new 11 beta-aryl substituted antigestagen: binding characteristics to receptor and serum proteins.
    Pollow K; Juchem M; Grill HJ; Manz B; Beier S; Henderson D; Schmidt-Gollwitzer K; Elger W
    Contraception; 1989 Aug; 40(2):213-32. PubMed ID: 2758842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3H-labelled RU 38486: characterization of binding sites in human uterine cytosol.
    Heubner A; Pollow K; Manz B; Grill HJ; Belovsky O
    J Clin Chem Clin Biochem; 1985 May; 23(5):265-76. PubMed ID: 4020325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
    Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
    J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative binding affinity of various progestins and antiprogestins to a rabbit myometrium receptor.
    Boonkasemsanti W; Aedo AR; Cekan SZ
    Arzneimittelforschung; 1989 Feb; 39(2):195-9. PubMed ID: 2730687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binding characteristics of RU 486 with glucocorticoid and progestin receptors].
    Fukuoka H; Jimbo T
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):698-706. PubMed ID: 3224726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
    Miller MM; Hurd C; Moudgil VK
    J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat uterine progesterone receptor: stabilization of hormone-binding components for biochemical analyses.
    Walters MR
    Arch Biochem Biophys; 1983 Sep; 225(2):656-66. PubMed ID: 6625605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.
    Mizutani T; Bhakta A; Kloosterboer HJ; Moudgil VK
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):695-704. PubMed ID: 1504008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative binding affinity of antiprogestins ZK 98.299 and ZK 98.734 for progesterone receptors in the endometrium and myometrium of bonnet monkeys.
    Pongubala JM; Elger WA; Puri CP
    J Recept Res; 1987; 7(6):903-20. PubMed ID: 3450874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.
    Moudgil VK; Hurd C
    Biochemistry; 1987 Aug; 26(16):4993-5001. PubMed ID: 3663641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
    Renoir JM; Radanyi C; Baulieu EE
    Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of female sexual behavior with intracerebral implants of antiprogestin RU 38486: correlation with binding to neural progestin receptors.
    Etgen AM; Barfield RJ
    Endocrinology; 1986 Oct; 119(4):1610-7. PubMed ID: 3757904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestodene: a novel synthetic progestin--characterization of binding to receptor and serum proteins.
    Pollow K; Juchem M; Grill HJ; Elger W; Beier S; Henderson D; Schmidt-Gollwitzer K; Manz B
    Contraception; 1989 Sep; 40(3):325-41. PubMed ID: 2548807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprogestin ZK-98.299 and progesterone display differential binding characteristics in the human myometrial cytosol.
    D'souza A; Hinduja IN; Puri CP
    Biochim Biophys Acta; 1992 Dec; 1175(1):73-80. PubMed ID: 1482698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
    Moudgil VK; Anter MJ; Hurd C
    J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the association of the progesterone receptor ligated by antiprogestin RU38486 or progestin ORG 2058 to chromatin components.
    Geier A; Bella R; Beery R; Haimsohn M; Lunenfeld B
    Biochim Biophys Acta; 1987 Oct; 931(1):78-86. PubMed ID: 3651513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologically distinct binding molecules for progesterone and RU38486 in the chick oviduct cytosol.
    Eliezer N; Hurd CB; Moudgil VK
    Biochim Biophys Acta; 1987 Jun; 929(1):34-9. PubMed ID: 3593772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of antiglucocorticoid RU 486 with rat kidney glucocorticoid receptor.
    Kalimi MY; Agarwal MK
    Biochem Biophys Res Commun; 1988 May; 153(1):365-71. PubMed ID: 3377791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.